OPA1 and hydrops fetalis: OPA1 can be considered a cardioprotective target for therapies against HF; indeed, enhancing fatty acid utilization in vivo through a high fat diet, OPA1 overexpression improved cardiac function by reducing mitochondrial fragmentation [91].